Bausch Health
BHC
#3605
Rank
S$3.91 B
Marketcap
$10.65
Share price
2.00%
Change (1 day)
1.48%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

Bausch Health (BHC) - Total debt

Total debt on the balance sheet as of June 2024 : S$28.21 B

According to Bausch Health 's latest financial reports the company's total debt is S$28.21 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Bausch Health - Total debt on balance sheet (from 1996 to 2023)

Total debt by year

Year Total debt Change
2023-12-31S$29.56 B6.21%
2022-12-31S$27.83 B-8.88%
2021-12-31S$30.55 B-3.41%
2020-12-31S$31.62 B-9.16%
2019-12-31S$34.82 B5.17%
2018-12-31S$33.10 B-2.71%
2017-12-31S$34.03 B-21.22%
2016-12-31S$43.19 B-1.91%
2015-12-31S$44.03 B118.77%
2014-12-31S$20.12 B-8.6%
2013-12-31S$22.02 B63.22%
2012-12-31S$13.49 B56.65%
2011-12-31S$8.61 B81.06%
2010-12-31S$4.75 B762.92%
2009-12-31S$0.55 B501.83%
2008-12-31S$91.6 M
2006-12-31S$0.62 B-13.46%
2005-12-31S$0.72 B2.99%
2004-12-31S$0.70 B-48.93%
2003-12-31S$1.38 B6.64%
2002-12-31S$1.29 B1417.51%
2001-12-31S$85.45 M-93.33%
2000-12-31S$1.28 B459.23%
1999-12-31S$0.22 B9.28%
1998-12-31S$0.20 B2436.03%
1997-12-31S$8.26 M-15.67%
1996-12-31S$9.79 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.35 B-98.76%๐Ÿ‡บ๐Ÿ‡ธ USA